Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 169   

Articles published

GSK 1,340.50 +9.50 (0.71%)
price chart
Is GlaxoSmithKline plc More Likely To Double In Value Than Hikma ...
GlaxoSmithKline (LSE: GSK) and Hikma Pharmaceuticals (LSE: HIK) have been under the spotlight for different reasons this week.
Why Growth And Income Hunters Should Check Out GlaxoSmithKline plc, Meggitt ...
I am convinced drugs giant GlaxoSmithKline (LSE: GSK) is a terrific stock selection for those seeking the prescription for plump returns.
Societe Generale Reiterates "Sell" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “sell” rating reissued by stock analysts at Societe Generale in a note issued to investors on Friday, Marketbeat.
GlaxoSmithKline plc Rating Reiterated by JPMorgan Chase & Co. (GSK)  The Legacy
GlaxoSmithKline plc 2.3% Potential Upside Indicated by JP Morgan Cazenove  DirectorsTalk Interviews
Is S & U PLC A Better Buy Than GlaxoSmithKline plc?
2015 has been a superb year for investors in lending specialist S&U (LSE: SUS), with the company posting a rise of 22% in its share price.
Beginners' Portfolio: What Have Vodafone Group plc, GlaxoSmithKline plc And ...
This article is the latest in a series that aims to help novice investors with the stock market. To enjoy past articles in the series, please visit our full archive.
Brokerages Set GlaxoSmithKline plc Target Price at $47.00 (NYSE:GSK)
GlaxoSmithKline plc logo Shares of GlaxoSmithKline plc (NYSE:GSK) have been assigned a consensus rating of “Hold” from the twenty-five ratings firms that are currently covering the company, Market Beat.
Large Outflow of Money Witnessed in GlaxoSmithKline PLC  Money Flow Index
GlaxoSmithKline PLC (NYSE:GSK) Price Target Update  News Watch International
Is GlaxoSmithKline plc's Dividend Safe?
GlaxoSmithKline (LSE: GSK) is often pegged as a super-safe income stock due to the rock solid demand for drugs - and its 5.8% dividend yield - but the fact is this business is in transition and at the moment its payout looks perilously uncovered ...
Better Dividend Stock: GlaxoSmithKline plc vs. AstraZeneca plc  Motley Fool
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain  Bidness ETC
5 Things GlaxoSmithKline Plc Wants You to Know
Late last month U.K.-based pharmaceutical giant GlaxoSmithKline (NYSE: GSK ) reported its second-quarter results, and for a change they didn't cause investors to run for the hills.
Do Results Make Hikma Pharmaceuticals Plc A Better Bet Than AstraZeneca plc ...
Who is the real competitor to AstraZeneca (LSE: AZN) and GlaxoSmithKline (LSE: GSK)? In an obvious way they're competing with each other and with the other major blockbuster drug researchers around the world.
GlaxoSmithKline PLC to divest ofatumumab for auto-immune indications to ...
GlaxoSmithKline plc LON:GSK NYSE:GSK today announced an agreement with Novartis Pharma AG, a subsidiary of Novartis AG NYSE:NVS, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis.
GSK - GlaxoSmithKline plc: GSK to divest ofatumumab for auto-immune ...  The Wall Street Transcript
Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop ...  Benzinga